Om Roy
CEO · AI and neuromodulation
University of Strathclyde
Non-invasive neuromodulation
Breaking the barrier to the brain.
Clinic-grade brain stimulation, guided by your phone and adapted by AI. No surgery. No hospital. No MRI.
Drag the brain to explore. Tap a region to target it.
Stimulation intensity
55%
Moderate
closed-loop, dose-limited
Research and advisory network
University of Nottingham
University of Strathclyde
University of Cambridge
Manufacturing partner secured
The problem
Everyone hears about brain tech.
Everyone hears about brain tech.
Almost no one benefits from it.
Implants are years away and unwanted. Clinic systems work but are tied to hospitals and scans. Consumer wearables are affordable but cannot reach deeper structures with any precision. The gap is wide open.
0
people will face anxiety, depression or cognitive fatigue in their lifetime, roughly 1 in 3.
0
deep brain stimulation procedures per year in the UK, across just 12 hospitals.
0
of people we surveyed would not consider a brain implant. The demand is for something non-invasive.
How it works
Clinic-grade targeting,
Clinic-grade targeting,
powered by a phone.
An ultrasound triangulation system pairs with a smartphone to guide stimulation to the right place, every session. A closed loop then reads your biosignals and adapts the dose in real time.
-
01
Precise placement
Put on the headset. Smartphone-based precision guidance positions the focal point accurately, without an MRI.
Smartphone-based guidance -
02
Reach the right target
Focused ultrasound reaches deep structures such as the thalamus and amygdala that generic wearables cannot address.
Focused ultrasound -
03
Adapt with AI
A closed loop reads EEG and HRV and tunes the dose during the session, getting smarter with every use.
Closed-loop personalisation
9:41
Focus and calm
4:12
of 10:00
Target
Thalamus
Position the headset
Positioning
Adjust headset position
Reading you in real time
EEG activity
Focused
Heart rate variability
62 bpm
Closed loop active - dose adapting
Insights
12
Sessions this month
94%
Adherence
Illustrative data shown.
The product
A clinic in your hands.
The companion app turns a complex therapy into a few simple taps: place, target, monitor and review. Clinicians stay in the loop with remote oversight throughout.
-
Guided placement
Step-by-step positioning so every session hits the intended target.
-
Real-time monitoring
EEG and HRV are read live and feed the closed loop that adapts the dose.
-
Clinician oversight
Sessions, adherence and safety limits are visible to your clinician remotely.
Why we win
The only approach that does all three.
Precision, home use and AI adaptation rarely live in the same device. DeepBrain is designed to bring them together.
| Capability | Implants | Clinic systems | Consumer wearables | DeepBrain |
|---|---|---|---|---|
| Non-invasive | No | Yes | Yes | Yes |
| Reaches deeper targets | Yes | Yes | No | Yes |
| Designed for home use | No | No | Yes | Yes |
| No MRI required | n/a | No | Yes | Yes |
| AI personalisation | Limited | Limited | No | Yes |
Comparison reflects DeepBrain’s design intent versus typical alternatives. All performance figures are design targets pending clinical confirmation.
Safety by design
Built to be used correctly,
Built to be used correctly,
every single time.
Home use only works if it is safe by default. Controls are designed in from the start, not bolted on later.
Dose ceilings
Hard limits cap intensity and duration, with one supervised session per day to prevent overuse.
Live monitoring
Biosignals are checked continuously, so the system can stop or adjust if readings fall outside expected ranges.
Clinician oversight
Remote supervision keeps a qualified professional in the loop for home sessions.
Secure by default
Device integrity and access controls, informed by security engineering expertise, guard against misuse.
Where we are going
A clear path from lab to living room.
Now / 6 months
Clinic validation
Working proof of concept with validated spatial accuracy. Next, clinic-led feasibility pilots to generate outcome data, starting with depression.
12 months
Clinical pilot
Structured clinician interviews and a clinical pilot, with safety, monitoring and the regulatory pathway toward UKCA and CE marking.
18 months
Supervised home use
Early rollouts of supervised home programmes with clinics and NHS innovation hubs, bundled with monitoring and personalisation software.
The team
World-leading experts across the stack.
Neuromodulation, brain-network science, biomedical engineering, AI and commercial execution, in one team.
Prof. Marcus Kaiser
CSO · Brain networks
University of Nottingham
Dr. Keith Smith
Biomedical Lead
University of Strathclyde
Dr. Yashar Moshfeghi
AI Lead
University of Strathclyde
Alex Christou
Business Development
University of Strathclyde
Advisory board
Peter SchlechtVenture capital
Prof. Feng HaoCambridge · Security engineering
Paul CableCEO · NeuPulse
Jon HackerCEO · NeurGear
Dave HughesCEO · Halya
Questions
Good things to know.
Get early access
Be first to bring the clinic home.
Join the waitlist for development updates, pilot opportunities and early access as DeepBrain moves from the lab toward the home.
No spam. Unsubscribe anytime.